Veterinary Injectable Devices Market size to exceed USD 1.5 Billion by 2034

Selbyville, DE. - The global veterinary injectable devices market was estimated at USD 931 million in 2024 and is expected to grow from USD 967.8 million in 2025 to USD 1.5 billion by 2034, at a CAGR of 4.9%, according to the latest report published by Global Market Insights Inc.

With more households adopting pets and treating them as family members, there is a significant rise in veterinary visits and preventive care spending—boosting demand for efficient, safe injectable devices for vaccinations, treatments, and therapies.

Key Insights:

Market Size & Growth:

• 2024 Market Size: USD 931 million
• 2025 Market Size: USD 967.8 million
• 2034 Forecast Market Size: USD 1.5 billion
• CAGR (2025–2034): 4.9%

Regional Insights:

• Largest Market: North America
• Fastest Growing Market: Asia Pacific
• Emerging Countries: China, India, Brazil, Mexico, South Africa 

Key Growth Drivers:

1. Growth in livestock production and animal protein demand: The global rise in meat and dairy consumption is driving livestock farming, which in turn increases the need for vaccination and disease control via injectable devices in large-scale animal health programs.
   
2. Increased focus on animal disease prevention and control: Governments and animal health organizations are placing greater emphasis on controlling zoonotic diseases and improving biosecurity.
   
3. Technological advancements in injection devices: Newer injection technologies such as auto-injectors, needle-free devices, and multi-dose systems are making administration safer, more accurate, and less stressful for both animals and veterinary professionals.
   
4. Veterinary infrastructure expansion in emerging markets: As veterinary clinics, animal hospitals, and mobile vet services grow in countries like India, Brazil, and Southeast Asia, access to injectable devices is improving, creating new revenue opportunities for manufacturers.
   
5. Supportive regulatory environment and product approvals: Regulatory bodies are increasingly supporting innovations in veterinary health with streamlined approvals for devices that ensure animal welfare and safety.
   

Key Players:

• Zoetis led the market with over 15.2% share in 2024.
  
• Some of the top players in this market include Henke-Sass, Wolf, NuGen Medical Devices, Merck & Co., Zoetis, and Neogen Corporation, which together held a 45% share in 2024.
  

Key Challenges:

1. High cost of advanced devices: Technologically advanced injectable devices such as auto-injectors and needle-free systems often come at a premium price, limiting their adoption.
   
2. Limited access to veterinary care in rural areas: Veterinary infrastructure is underdeveloped or concentrated in urban areas, restricting the distribution and usage of injectable devices in rural regions where livestock farming is prevalent.
   
3. Risk of improper administration and user error: Without adequate training, improper injection techniques can lead to underdosing, overdosing, or injuries to animals, affecting treatment outcomes and potentially causing resistance or complications.
   
4. Strict regulatory compliance and approval delays: Veterinary medical devices must meet stringent safety and efficacy standards.
   
5. Concerns over needle reuse and biosecurity: There is a risk of needle reuse due to cost constraints or poor waste management practices, increasing the chances of infection transmission and compromising animal welfare.
   

Browse key industry insights spread across 172 pages with 154 market data tables and figures from the report, “Veterinary Injectable Devices Market - By Product, By Material, By Clinical Application, By Usage, By Animal Type, By End Use - Global Forecast, 2025-2034” in detail, along with the table of contents:

https://www.gminsights.com/industry-analysis/veterinary-injectable-devices-market

Rising adoption of Syringes

The syringes segment held a notable share in 2024, driven by its wide applicability in administering medications, vaccines, and nutrients to both companion and livestock animals. These devices are valued for their precision, ease of use, and compatibility with a range of needle gauges and volumes. As infection control remains a priority, the industry is witnessing increased production of pre-sterilized and safety-enhanced syringes tailored for veterinary use.

Plastic Material to Gain Traction

The plastic materials generated a significant share in 2024 owing to their cost-effectiveness, lightweight nature, and flexibility in design. From disposable syringes to multi-dose injectors, plastic offers a balance of durability and safety. The market growth is driven by high-volume production needs and the rising demand for single-use devices that support hygienic practices in both clinics and farm environments. Manufacturers are also exploring eco-friendly bioplastics and recyclable polymers to address growing environmental concerns and align with sustainability goals.

Rising Demand for Vaccination and Preventive Care

The vaccination and preventive care segment generated significant revenues in 2024, fueled by increasing awareness of disease prevention in both pets and livestock. Veterinarians and animal health programs are prioritizing injectable vaccines for their fast action and high efficacy, especially for diseases like rabies, foot-and-mouth, and parvovirus. Injectable devices designed for speed, accuracy, and reduced stress on animals are in high demand, particularly in large-scale vaccination drives.

North America to Emerge as a Propelling Region

North America veterinary injectable devices market held a substantial share in 2024, backed by advanced veterinary healthcare systems, high pet ownership rates, and strong livestock management practices. Growth is supported by increased investments in animal wellness, widespread adoption of preventive care protocols, and a favorable regulatory environment. The presence of key players and ongoing R&D efforts also contributes to the region’s dominance, with a focus on precision devices and digital tracking systems for dosage accuracy.

Major players involved in the veterinary injectable devices market are Neogen Corporation, Terumo Medical Corporation, Hamilton Company, Serumwerk Bernburg, Allflex USA, Medtronic plc, Zoetis, Henke-Sass, Wolf, Baxter International, NuGen Medical Devices, B. Braun Melsungen, Merck & Co., Micrel Medical Devices.

To strengthen their market position, leading companies in the veterinary injectable devices space are focusing on innovation, geographic expansion, and strategic collaborations. Product development is centered around ergonomic designs, needle-free injectors, and automated dosing systems to reduce human error and animal stress. Many players are expanding into emerging markets by setting up local manufacturing and distribution partnerships to lower costs and improve reach.